MedDataX Logo

Non-invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis

NCT ID: NCT03049709

Last Updated: 2017-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

119 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-01

Study Completion Date

2017-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is growing evidence that central blood pressure is a better predictor of hypertensive end-organ damage and cardiovascular outcome than routine brachial readings.

The investigators aimed to evaluate the accuracy of a novel device for the non-invasive determination of central blood pressure based on automated oscillometric radial pulse wave analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arterial Hypertension Healthy Control Coronary Heart Disease Diabetes Mellitus

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

central blood pressure measurement oscillometric radial pulse wave analysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cardiovascular disease

patients with cardiovascular disease, invasive and non-invasive determination of central blood pressure

No interventions assigned to this group

healthy controls

healthy controls, invasive and non-invasive determination of central blood pressure

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cardiovascular disease, diabetes mellitus or healthy control

Exclusion Criteria

* inability to give informed consent
* hemodynamic instability
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitätsmedizin Mannheim

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Frederik Trinkmann

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jens J Kaden, MD

Role: PRINCIPAL_INVESTIGATOR

Universitätsmedizin Mannheim

Joachim Saur, MD

Role: PRINCIPAL_INVESTIGATOR

Universitätsmedizin Mannheim

Urs Benck, MD

Role: PRINCIPAL_INVESTIGATOR

Universitätsmedizin Mannheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitätsmedizin Mannheim

Mannheim, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VA_noninvasive

Identifier Type: -

Identifier Source: org_study_id